Clover Health Investments (CLOV) Common Equity (2019 - 2026)

Clover Health Investments' Common Equity history runs 8 years deep, the most recent figure standing at $339.4 million for Q1 2026.

• Quarterly Common Equity rose 1.0% year-over-year to $339.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $339.4 million (up 1.0% YoY) and the FY2025 annual result came in at $308.7 million, down 9.51% from the prior year.
• Common Equity was $339.4 million for Q1 2026 at Clover Health Investments, up from $308.7 million in the prior quarter.
• Across five years, Common Equity topped out at $490.4 million in Q1 2022 and bottomed at $286.4 million in Q4 2023.
• A 5-year average of $347.0 million and a median of $339.4 million in 2026 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity surged 35.71% — and 2023, when it sank 34.11%.
• Clover Health Investments' Common Equity stood at $356.9 million in 2022, then decreased by 19.75% to $286.4 million in 2023, then grew by 19.12% to $341.1 million in 2024, then decreased by 9.51% to $308.7 million in 2025, then rose by 9.95% to $339.4 million in 2026.
• Business Quant data shows CLOV's Common Equity at $339.4 million in Q1 2026, $308.7 million in Q4 2025, and $340.9 million in Q3 2025.